SIT 3.3 Bn Profit at Q3 for Krka Pharmaceuticals
Novo Mesto, 17 December - ENTERPRISES/KRKA
Pharmaceuticals-maker Krka made SIT 38 billion of sales (about US$ 237.5 m) in the first nine months of the year, up 12 percent y/y. Profits in the January -September period amounted to SIT 3.3 billion (US$ 20.6m).
The rest of this news item is available to subscribers.
The news item consists of 617 characters (without spaces) or 120 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.